Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVX | Common Stock | Options Exercise | $1.04M | +9K | +1349.33% | $116.00 | 9.67K | Mar 1, 2022 | Direct | F1 |
transaction | CVX | Common Stock | Sale | -$1.31M | -9K | -93.1% | $145.02 | 667 | Mar 1, 2022 | Direct | F1, F2 |
holding | CVX | Common Stock | 4.94K | Mar 1, 2022 | by 401(k) plan | ||||||
holding | CVX | Common Stock | 1.88K | Mar 1, 2022 | UK benefits plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -9K | -100% | $0.00* | 0 | Mar 1, 2022 | Common Stock | 9K | $116.00 | Direct | F3 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2021. |
F2 | This transaction was executed in multiple trades at prices ranging from $145.00 to $145.06. The price reported above reflects the weighted-average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided. |
F3 | Option granted 1/29/2014. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant. |